Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia: a randomized clinical trial
Rybelsus | European Medicines Agency (EMA)
Well dive into the latest research and its implications for those on GLP-1 receptor agonists
Diabetol Metab Syndr 15(1):53 Benz E, Pinel A, Guillet C, Capel F, Pereira B, De Antonio M et al (2024) Sarcopenia and sarcopenic obesity and mortality among older people
Mechanism Although the exact mechanisms underlying GLP-1 RA-induced diabetic retinopathy remain unclear, several hypotheses have been proposed
Tablets avoid needles, but they still work through the same GLP-1 pathway and can cause similar side effects